A Phase 3, Study to Assess the Efficacy, Safety and Tolerability of ASP1941 in Combination With Metformin in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin Alone.
Phase of Trial: Phase III
Latest Information Update: 10 Jan 2012
At a glance
- Drugs Ipragliflozin; Metformin
- Indications Type 2 diabetes mellitus
- Focus Registrational; Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 10 Jan 2012 Actual end date (dec 2011) added as reported by ClinicalTrials.gov.
- 10 Jan 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.